All Day

2nd RNA Editing Summit

As CRISPR genome editing struggles to overcome key specificity and delivery challenges in its pursuit to realize therapeutic applications, the 2nd RNA Editing Summit returns to help you accelerate the...

Informa Connect’s Rare Disease Summit

CBI/EBD Group’s Rare Disease Summit convenes industry, patient groups, investors and policy makers to unite in areas of unmet medical need and create life-transforming therapies and breakthroughs. KEYNOTES FOR 2020!...

MassBio Town Hall – 2021 Biotech Outlook

MassBio’s President & CEO, Bob Coughlin, will host a regular virtual Town Hall for members. This will be an opportunity for our members to ask questions, hear what MassBio is...

Webinar: 2021 Preview: A 360 Degree Global Market View

Join BIO and LaVoieHealthScience for our next Global Market View webinar on December 1 at 10:30AM ET. Our panel of industry leaders with share their perspectives on several topics including...

Bayer BioLyceum

The prospect of raising capital for early stage companies (pre-seed to Series A) in times of uncertainty always present challenges. Funders continue to invest in companies they have worked with...